+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID06150560

Evaluating Losartan and Amlodipine for Cardiovascular Remodeling in Patients with Repaired Coarctation of Aorta and High Blood Pressure

Led by Mayo Clinic · Updated on 2026-09-11

120

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the effects and action of Losartan, an angiotensin-II receptor blocker, in treating patients with repaired coarctation of the aorta who also have high blood pressure. This Phase III clinical trial aims to compare Losartan with Amlodipine and a placebo to understand their impact on cardiovascular remodeling. Participants will be randomly assigned to one of three groups Losartan 50mg daily, Amlodipine 5mg daily, or a placebo, all taken orally once a day for 52 weeks. The study uses a double-blind design, so neither participants nor researchers know which treatment is given. The trial focuses on supportive care to evaluate changes in the hearts left ventricular fibrosis and exercise capacity over one year. During the study, participants will undergo assessments at the start and after 52 weeks. These include measuring heart tissue changes and exercise capacity. Researchers will monitor health and safety throughout the trial. The total participation time is about one year, including treatment and follow-up evaluations.

CONDITIONS

Brief Title

A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)

Research Team

A

ACHD Research Program

A

Alexander Egbe, MBBS, MPH

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here